Cleveland BioLabs, Inc. Made Big Gain

Cleveland BioLabs, Inc. (CBLI:NASDAQ) rocketted at $0.94, representing a gain of 48.8%. On Mon 25 Nov 19, CBLI:NASDAQ touched a New 2-Week Intraday Low of $0.5. The stock appeared on our News Catalysts scanner on Thu 14 Nov 19 at 05:32 PM in the 'EARNINGS' category. From Tue 05 Nov 19, the stock recorded 42.86% Up Days and 33.33% Green Days

The share price of the company has been moving sideways in recent weeks.

About Cleveland BioLabs, Inc. (CBLI:NASDAQ)

Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.